China Metastatic Liver Cancer Clinical Registry Cohort Database

Recruiting Observational Study
Liver Metastases Metastases to Liver Liver Cancer Neoplasms Liver Diseases Colorectal Cancer Metastatic
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Observational
Participants needed
2,000 (estimated)
Sponsor
Anhui Provincial Hospital · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study is led by the Department of Hepatobiliary Surgery of the First Affiliated Hospital of the University of Science and Technology of China (USTC), in close collaboration with multiple participating centers nationwide. The primary objective is to establish a standardized, large-scale clinical cohort database specifically for metastatic liver cancer. By collecting comprehensive data on patie…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients with histologically or radiologically confirmed metastatic liver cancer. 2. Age ≥ 18 years. 3. Patients who have voluntarily signed the informed consent form. 4. Patients with complete baseline clinical data. Exclusion Criteria: 1. Patients with primary liver cance…
Contacts

Jizhou Wang, MD PhD

+86 13836135864

wangjoe@ustc.edu.cn

CONTACT

Lianxin Liu, MD PhD

+86 13845159888

liulx@ustc.edu.cn

CONTACT